Breakthrough in Cancer Immunotherapy: Macrophage Membrane-coated Nanoparticles Show Promising Results

Scientists at MuDanJiang Medical University have developed a groundbreaking cancer treatment using macrophage membrane-coated nanoparticles, which have shown exceptional efficacy in targeting and killing cancer cells. These nanoparticles, called MGLD (Macrophage membrane/gelatin/laponite/doxorubicin), were engineered to evade immune clearance and induce autophagy and immunogenic cell death (ICD) in cancer cells.

Key Takeaways:

• The MGLD nanoparticles, approximately 130 nm in size, were designed to enhance tumor targeting, prevent immune clearance, and induce autophagy and ICD in cancer cells.
• In vitro and in vivo assays evaluated the nanoparticles' accumulation, penetration, cytotoxicity in tumor tissues, and ability to induce immunogenic cell death (ICD).
• The results demonstrated that MGLD nanoparticles accumulated in tumors, penetrated deep into tissues, and induced ICD with minimal macrophage toxicity.
• The acidic tumor microenvironment and MMP-2 facilitated rapid DOX release, enhancing anticancer efficacy with minimal macrophage toxicity.
• MGLD showed excellent stability, pH sensitivity, and negligible in vivo toxicity, stimulating autophagy and ICD.
• The research concluded that MGLD nanoparticles are a promising candidate for targeted cancer therapy, enhancing drug targeting and efficacy while overcoming the limitations of conventional chemotherapy.

Statistics:

• 130 nm: the approximate size of the MGLD nanoparticles.
• 27(5): 739-758: the volume and page range of the publication "Macrophage Membrane-coated Gelatin/laponite Nanoparticles Containing Doxorubicin for Anticancer Immunotherapy" in the journal Oncologie.
• 2025: the year of publication for the research.
• 1.33 μm: the penetration capacity of MGLD nanoparticles in tumor tissues.
• 20-70%: the range of in vivo toxicity observed in mice treated with MGLD nanoparticles.

Sources:

• NewsRx. Study Findings from MuDanJiang Medical University Broaden Understanding of Cancer (Macrophage Membrane-coated Gelatin/laponite Nanoparticles Containing Doxorubicin for Anticancer Immunotherapy). Cancer Weekly. October 14, 2025; p 5477.
• Oncologie, 2025;27(5):739-758.